Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH analog detection and hormonal effects study in healthy men
ACTRN12609000189224Phase 4Not yet recruiting
- Sponsor
- Sydney South West Area Health Authority
- Start
- Jan 2009
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of leuprolide, testosterone, nandrolone and saline (4 arms), sponsored by Sydney South West Area Health Authority. Primary endpoint: Hormonal effects on sports doping markers. Planned start Jan 2009; status: not yet recruiting.
02
Drugs
leuprolidetestosteronenandrolonesaline
Beyond the preview
Go deeper on ACTRN12609000189224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000189224.